Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Artificial intelligence and epilepsy: Dr. Christian Bosselmann

Artificial intelligence and epilepsy: Dr. Christian Bosselmann

FromSharp Waves: ILAE's epilepsy podcast


Artificial intelligence and epilepsy: Dr. Christian Bosselmann

FromSharp Waves: ILAE's epilepsy podcast

ratings:
Length:
37 minutes
Released:
Jun 5, 2023
Format:
Podcast episode

Description

Discussions of artificial intelligence and ChatGPT are everywhere. How will this technology affect epilepsy research and care? What are the dangers and pitfalls, and what do we need to know when designing research studies that use AI technology?Dr. Alina Ivaniuk interviewed Dr. Christian Bosselmann, an epilepsy precision medicine research fellow at the Cleveland Clinic, about the history of chatbots, the promise and pitfalls of artificial intelligence, and tips for critically evaluating studies that utilize AI.Mentioned in the discussion: Are AI language models such as ChatGPT ready to improve the care of individuals with epilepsy?Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forumThis episode was reported by Alina Ivaniuk, and edited and produced by Nancy Volkers.Feedback and ideas welcome: podcast@ilae.org Support the showSharp Waves episodes are meant for informational purposes only, and not as clinical or medical advice.The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram.
Released:
Jun 5, 2023
Format:
Podcast episode

Titles in the series (56)

Epilepsy affects more than 50 million people. Every day. Sharp Waves brings you stories about people with epilepsy, physicians treating epilepsy, and researchers studying the condition. We'll cover the latest research, challenges to diagnosis and treatment, and issues from around the world.